These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 9456667

  • 1. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.
    White TC, Pfaller MA, Rinaldi MG, Smith J, Redding SW.
    Oral Dis; 1997 May; 3 Suppl 1():S102-9. PubMed ID: 9456667
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
    Johnson EM, Warnock DW, Luker J, Porter SR, Scully C.
    J Antimicrob Chemother; 1995 Jan; 35(1):103-14. PubMed ID: 7768758
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J.
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [Abstract] [Full Text] [Related]

  • 5. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P, Lopez J, Grappin M, Bonnin A, Duong M, Waldner A, Buisson M, Camerlynck P, Portier H.
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
    Barchiesi F, Arzeni D, Del Prete MS, Sinicco A, Falconi Di Francesco L, Pasticci MB, Lamura L, Nuzzo MM, Burzacchini F, Coppola S, Chiodo F, Scalise G.
    J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
    [Abstract] [Full Text] [Related]

  • 9. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
    Samaranayake YH, Samaranayake LP, Tsang PC, Wong KH, Yeung KW.
    J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319
    [Abstract] [Full Text] [Related]

  • 10. Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
    Cartledge JD, Midgley J, Gazzard BG.
    AIDS; 1997 Dec; 11(15):1839-44. PubMed ID: 9412702
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
    Walsh TJ, Kasai M, Francesconi A, Landsman D, Chanock SJ.
    J Med Vet Mycol; 1997 Dec; 35(2):133-7. PubMed ID: 9147273
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.
    Perea S, López-Ribot JL, Kirkpatrick WR, McAtee RK, Santillán RA, Martínez M, Calabrese D, Sanglard D, Patterson TF.
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2676-84. PubMed ID: 11557454
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oral transmission of Candida albicans between partners in HIV-infected couples could contribute to dissemination of fluconazole-resistant isolates.
    Dromer F, Improvisi L, Dupont B, Eliaszewicz M, Pialoux G, Fournier S, Feuillie V.
    AIDS; 1997 Jul 15; 11(9):1095-101. PubMed ID: 9233455
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
    Anil S, Ellepola AN, Samaranayake LP.
    J Oral Pathol Med; 2001 Sep 15; 30(8):481-8. PubMed ID: 11545239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.